| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Propofol | FAERS: 8 | US FAERS | |
| 2 | Dimethyl Fumarate | FAERS: 4 | US FAERS | |
| 3 | Norgestrel | FAERS: 4 | US FAERS | |
| 4 | Bosentan | FAERS: 3 | OFFSIDES US FAERS | |
| 5 | Rivaroxaban | FAERS: 3 | US FAERS | |
| 6 | carbidopa, levodopa drug combination | FAERS: 3 | US FAERS | |
| 7 | paricalcitol | FAERS: 3 | OFFSIDES US FAERS | |
| 8 | Clozapine | FAERS: 2 | US FAERS | |
| 9 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 10 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 11 | Ruxolitinib phosphate | FAERS: 2 | US FAERS | |
| 12 | apremilast | FAERS: 2 | US FAERS | |
| 13 | Baclofen | FAERS: 1 | US FAERS | |
| 14 | Ceftazidime | FAERS: 1 | US FAERS | |
| 15 | Clopidogrel | FAERS: 1 | US FAERS | |
| 16 | Deferasirox | FAERS: 1 | US FAERS | |
| 17 | LCZ 696 | FAERS: 1 | US FAERS | |
| 18 | Lenalidomide | FAERS: 1 | US FAERS | |
| 19 | Metformin | FAERS: 1 | US FAERS | |
| 20 | Metformin | FAERS: 1 | US FAERS | |
| 21 | Pergolide | FAERS: 1 | US FAERS | |
| 22 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 23 | Simvastatin | FAERS: 1 | US FAERS | |
| 24 | Sirolimus | FAERS: 1 | US FAERS | |
| 25 | Sorafenib | FAERS: 1 | US FAERS | |
| 26 | Tapentadol | FAERS: 1 | US FAERS | |
| 27 | ambrisentan | FAERS: 1 | US FAERS | |
| 28 | apixaban | FAERS: 1 | US FAERS | |
| 29 | etonogestrel | FAERS: 1 | US FAERS | |
| 30 | liposomal doxorubicin | FAERS: 1 | US FAERS | |
| 31 | Bupropion | OFFSIDES | ||
| 32 | Octreotide | Canada Vigilance: 1 | Canada Vigilance | |
| 33 | Sevelamer | OFFSIDES | ||
| 34 | Sumatriptan | OFFSIDES | ||
| 35 | benazepril | OFFSIDES | ||
| 36 | fludarabine phosphate | OFFSIDES | ||
| 37 | fludarabine | OFFSIDES | ||
| 38 | telithromycin | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.